GERN FY 2021 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+450.6% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$114M-8183.7% margin

Net Income

-$116M-8335.4% margin

EPS (Diluted)

$-0.37

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$96M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$226M

Total Liabilities

$100M

Stockholders' Equity

$126M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$253,000	+450.6%
Gross Profit	$1M	-$50M	+102.8%
Operating Income	-$114M	-$77M	-48.2%
Net Income	-$116M	-$76M	-53.6%